Log In

 

Company Name : ResMed

Wednesday, January 9, 2019 12:25PM IST (6:55AM GMT)

(BW)(CA-RESMED)

Mobi Is Here: ResMed’s First Portable Oxygen Device Now Widely Available in the U.S.


San Diego, United States

  • Mobi delivers an optimal balance of oxygen output, battery life and weight for effective therapy wherever people go
  • ResMed’s growing COPD portfolio now helps treat people in most stages of their disease

ResMed (NYSE: RMD, ASX: RMD), a leader in respiratory care medical devices and out-of-hospital care software, announced that its premier portable oxygen concentrator, Mobi, is now widely available in the United States.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190108005318/en/

 
ResMed Mobi portable oxygen concentrator, with carry bag (Photo: Business Wire)

ResMed Mobi portable oxygen concentrator, with carry bag (Photo: Business Wire)

Mobi offers an optimal balance of oxygen delivery, weight and battery life so that millions of people with chronic obstructive pulmonary disease (COPD) or other chronic diseases can enjoy ResMed-quality oxygen therapy wherever they go.

 

“Simply put, Mobi keeps you mobile, which research shows is so important in terms of helping people with COPD lower their risk of hospitalization and early death,” said ResMed Respiratory Care President Richie McHale. “Mobi’s ideal balance of weight, battery life and oxygen output empowers people to stay active, and live their lives to the fullest.”

 

ResMed now offers a wide variety of solutions to help people manage their COPD at most stages: Mobi for people requiring oxygen therapy, Astral and AirCurve 10 ST-A devices for cloud-connected in-home ventilation, for people with severe COPD. Propeller rounds out this portfolio with mild- to moderate-stage COPD solutions.

 

“The broad suite of devices ResMed now offers to treat COPD at different stages is truly life-changing,” McHale said. “But really we’re just getting started in terms of helping 380 million people with COPD improve their quality of life, reduce the impact of chronic disease, and lower healthcare costs,” McHale said.

 

Mobi will be available in other countries later this year, pending regulatory approval.

 

About ResMed

 

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries. To learn more, visit ResMed.com and follow @ResMed.

 

 
MULTIMEDIA AVAILABLE :
https://www.businesswire.com/news/home/20190108005318/en/


Click here for Media Contact Details
CONTACTS :

For media:
Jayme Rubenstein
+1 858-836-6798
news@resmed.com

For investors:
Amy Wakeham
+1 858-836-5000
investorrelations@resmed.com


More News from ResMed

08/01/2019 12:35PM

ResMed Completes $225 Million Acquisition of Propeller Health

ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its acquisition of Propeller Health, a ...

04/12/2018 11:35AM

ResMed to Acquire Propeller Health, a Leader in COPD and Asthma Connected Health Solutions, for $225 Million

Establishes ResMed as a leader in COPD patient management, across all stages of the disease Propeller Health will operate as a standalone business, maintaining its COPD and asthma product solutions, as well as its ...

21/11/2018 10:02AM

ResMed Elects Harjit Gill to Its Board of Directors

ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service business solutions, announced it has elected experienced consumer and healthcare executive Harjit Gill ...

Similar News

19/01/2019 5:03PM

Schlumberger Announces Full-Year and Fourth-Quarter 2018 Results

Full-year revenue of $32.8 billion increased 8% year-on-year Full-year GAAP EPS, including charges & credits, was $1.53 Full-year EPS, excluding charges & credits, of $1.62 increased 8% ...

No Image

18/01/2019 7:31PM

Wipro Limited Announces Results for the Quarter ended December 31, 2018 under IFRS

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) today announced financial results under International Financial Reporting Standards (IFRS) for its quarter ended December 31, 2018.